Literature DB >> 21952623

Adenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effects.

Q Li1, K Kawamura, S Okamoto, H Fujie, M Numasaki, M Namba, M Nagata, H Shimada, H Kobayashi, M Tagawa.   

Abstract

BACKGROUND: Interferon-λs (IFN-λs) are novel cytokines with multiple functions, like IFN-α and -β. We examined possible anti-tumour effects produced by adenoviruses bearing the IFN-λ1 or -λ2 gene (Ad/IFN-λ) with the type-35 fibre-knob structure.
METHODS: Proliferation of oesophageal carcinoma cells transduced with Ad/IFN-λ and mechanisms of the inhibited growth were investigated.
RESULTS: Transduction with Ad/IFN-λ upregulated the expression of the class I antigens of the major histocompatibility complexes and induced the growth suppression. Increased sub-G1 populations and the cleavage of caspase-3 and poly (ADP-ribose) polymerase were detected in IFN-λ-sensitive YES-2 and T.Tn cells. The cell death was accompanied by cytoplasmic cytochrome C and increased cleaved caspase-9 and Bax expression, suggesting mitochondria-mediated apoptosis. Adenovirus/IFN-λ-infected YES-2 cells subsequently reduced the tumourigenicity. Adenovirus/IFN-λ-infected fibroblasts, negative for the IFN-λ receptors, induced death of YES-2 or T.Tn cells that were co-cultured. Inoculation of YES-2 cells in nude mice, when mixed with the Ad/IFN-λ-infected fibroblasts, resulted in retardation of the tumour growth. The growth suppression was not linked with upregulated CD69 expression on natural killer cells or increased numbers of CD31-positive cells.
CONCLUSION: Adenovirus/IFN-λ induced apoptosis, and fibroblast-mediated delivery of IFN-λs is a potential cancer treatment by inducing direct cell death of the target carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952623      PMCID: PMC3241552          DOI: 10.1038/bjc.2011.379

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Antitumor activity of IFN-lambda in murine tumor models.

Authors:  Atsuko Sato; Mamitaro Ohtsuki; Megumi Hata; Eiji Kobayashi; Takashi Murakami
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

2.  IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro.

Authors:  Giovanni Vitale; Wouter W de Herder; Peter M van Koetsveld; Marlijn Waaijers; Wenda Schoordijk; Ed Croze; Annamaria Colao; Steven W J Lamberts; Leo J Hofland
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

3.  IL-28 elicits antitumor responses against murine fibrosarcoma.

Authors:  Muneo Numasaki; Masatoshi Tagawa; Fumi Iwata; Takashi Suzuki; Akira Nakamura; Masahiro Okada; Yoichiro Iwakura; Setsuya Aiba; Mutsuo Yamaya
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

4.  IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression.

Authors:  Stephan Brand; Florian Beigel; Torsten Olszak; Kathrin Zitzmann; Sören T Eichhorst; Jan-Michel Otte; Joachim Diebold; Helmut Diepolder; Barbara Adler; Christoph J Auernhammer; Burkhard Göke; Julia Dambacher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-07-28       Impact factor: 4.052

5.  Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.

Authors:  Tobias Marcello; Arash Grakoui; Giovanna Barba-Spaeth; Erica S Machlin; Sergei V Kotenko; Margaret R MacDonald; Charles M Rice
Journal:  Gastroenterology       Date:  2006-10-01       Impact factor: 22.682

6.  Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.

Authors:  Ahmed Lasfar; Anita Lewis-Antes; Sergey V Smirnov; Shubha Anantha; Walid Abushahba; Bin Tian; Kenneth Reuhl; Harold Dickensheets; Faruk Sheikh; Raymond P Donnelly; Elizabeth Raveche; Sergei V Kotenko
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

7.  Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells.

Authors:  Kathrin Zitzmann; Stephan Brand; Sebastian Baehs; Burkhard Göke; Jennifer Meinecke; Gerald Spöttl; Heinrich Meyer; Christoph J Auernhammer
Journal:  Biochem Biophys Res Commun       Date:  2006-04-24       Impact factor: 3.575

Review 8.  Mesenchymal stem cells: an emerging tool for cancer targeting and therapy.

Authors:  Vanessa Fritz; Christian Jorgensen
Journal:  Curr Stem Cell Res Ther       Date:  2008-01       Impact factor: 3.828

9.  A comparison of the antitumor effects of interferon-alpha and beta on human hepatocellular carcinoma cell lines.

Authors:  Masayuki Murata; Shigeki Nabeshima; Kensuke Kikuchi; Kouzaburo Yamaji; Norihiro Furusyo; Jun Hayashi
Journal:  Cytokine       Date:  2006-03-07       Impact factor: 3.861

10.  IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.

Authors:  Caroline Sommereyns; Sophie Paul; Peter Staeheli; Thomas Michiels
Journal:  PLoS Pathog       Date:  2008-03-14       Impact factor: 6.823

View more
  7 in total

Review 1.  Investigations of interferon-lambda for the treatment of cancer.

Authors:  Andrew Stiff; William Carson
Journal:  J Innate Immun       Date:  2015-02-06       Impact factor: 7.349

2.  Recombinant adenovirus expressing hIFN-λ1 inhibits gastric adenocarcinoma cell line SGC-7901 proliferation.

Authors:  Xuefeng Bu; Mubin Wang; Jie Zhang; Jun Liu; Lijuan Jia; Bing Liang; Yulan Yan
Journal:  Oncol Lett       Date:  2015-11-06       Impact factor: 2.967

Review 3.  Interferon-λs: special immunomodulatory agents and potential therapeutic targets.

Authors:  Ya-wen Zheng; Hui Li; Jin-pu Yu; Hua Zhao; Shizhen Emily Wang; Xiu-bao Ren
Journal:  J Innate Immun       Date:  2012-11-30       Impact factor: 7.349

4.  Adenovirus expressing IFN-λ (Ad/hIFN-λ) produced anti-tumor effects through inducing apoptosis in human tongue squamous cell carcinoma cell.

Authors:  Bing Song; Yong Yang; Yan-Li Wang; Xiao-Hui Fan; Yu-Mei Huang; Hao-Su Ci; Jin-Hua Zuo
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1.

Authors:  K Hasegawa; M Tagawa; K Takagi; H Tsukamoto; Y Tomioka; T Suzuki; Y Nishioka; T Ohrui; M Numasaki
Journal:  Cancer Gene Ther       Date:  2016-08-19       Impact factor: 5.854

6.  Long non-coding RNA GAS5 is induced by interferons and plays an antitumor role in esophageal squamous cell carcinoma.

Authors:  Jianbing Huang; Yuan Li; Zhiliang Lu; Yun Che; Shouguo Sun; Shuangshuang Mao; Yuanyuan Lei; Ruochuan Zang; Ning Li; Nan Sun; Jie He
Journal:  Cancer Med       Date:  2018-05-09       Impact factor: 4.452

7.  Recombinant Newcastle disease virus expressing human IFN-λ1 (rL-hIFN-λ1)-induced apoptosis of A549 cells is connected to endoplasmic reticulum stress pathways.

Authors:  Yulan Yan; Sha Liu; Mi Li; Yinghai Zhao; Xiaomei Shao; Min Hang; Xuefeng Bu
Journal:  Thorac Cancer       Date:  2018-09-23       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.